Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma

S. Komiyama, Daisuke Aoki, E. Saitoh, M. Komiyama, Y. Udagawa

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasminogen activator inhibitor-1 (PAI-1) expression in patients with OCCA and attempted to assess its biological significance. Methods: Fifty-seven patients with OCCA were enrolled. We used formalin-fixed, paraffin-embedded sections of the primary tumor obtained at the first operation to investigate the immunohistochemical expression of PAI-1 and the association of PAI-1 expression with various clinico-pathologic factors. Results: The 57 patients were classified into a high PAI-1 expression group and a low expression group. Comparison between the two groups revealed that the percentage of patients with concomitant endometriosis was significantly larger in the high expression group, while the percentage of Stage I patients with positive peritoneal cytology was significantly larger in the low expression group. Comparison of cumulative 5-year survival rates showed that the high expression group had a better prognosis than the low expression group. Conclusion: These data suggest an association between concomitant endometriosis and increased expression of PAI-1 in OCCA. The data also suggest that PAI-1 expression influences both peritoneal dissemination of early OCCA and the prognosis.

Original languageEnglish
Pages (from-to)611-614
Number of pages4
JournalEuropean Journal of Gynaecological Oncology
Volume32
Issue number6
Publication statusPublished - 2011

Fingerprint

Clear Cell Adenocarcinoma
Plasminogen Activator Inhibitor 1
Endometriosis
Paraffin
Formaldehyde
Cell Biology
Adenocarcinoma
Survival Rate

Keywords

  • Clear cell adenocarcinoma
  • Endometriosis
  • Ovarian cancer
  • Peritoneal cytology
  • Plasminogen activator inhibitor-1
  • Prognosis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma. / Komiyama, S.; Aoki, Daisuke; Saitoh, E.; Komiyama, M.; Udagawa, Y.

In: European Journal of Gynaecological Oncology, Vol. 32, No. 6, 2011, p. 611-614.

Research output: Contribution to journalArticle

@article{7e7a5950a9b94daf957e27c3ecb08dd7,
title = "Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma",
abstract = "Purpose: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasminogen activator inhibitor-1 (PAI-1) expression in patients with OCCA and attempted to assess its biological significance. Methods: Fifty-seven patients with OCCA were enrolled. We used formalin-fixed, paraffin-embedded sections of the primary tumor obtained at the first operation to investigate the immunohistochemical expression of PAI-1 and the association of PAI-1 expression with various clinico-pathologic factors. Results: The 57 patients were classified into a high PAI-1 expression group and a low expression group. Comparison between the two groups revealed that the percentage of patients with concomitant endometriosis was significantly larger in the high expression group, while the percentage of Stage I patients with positive peritoneal cytology was significantly larger in the low expression group. Comparison of cumulative 5-year survival rates showed that the high expression group had a better prognosis than the low expression group. Conclusion: These data suggest an association between concomitant endometriosis and increased expression of PAI-1 in OCCA. The data also suggest that PAI-1 expression influences both peritoneal dissemination of early OCCA and the prognosis.",
keywords = "Clear cell adenocarcinoma, Endometriosis, Ovarian cancer, Peritoneal cytology, Plasminogen activator inhibitor-1, Prognosis",
author = "S. Komiyama and Daisuke Aoki and E. Saitoh and M. Komiyama and Y. Udagawa",
year = "2011",
language = "English",
volume = "32",
pages = "611--614",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "6",

}

TY - JOUR

T1 - Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma

AU - Komiyama, S.

AU - Aoki, Daisuke

AU - Saitoh, E.

AU - Komiyama, M.

AU - Udagawa, Y.

PY - 2011

Y1 - 2011

N2 - Purpose: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasminogen activator inhibitor-1 (PAI-1) expression in patients with OCCA and attempted to assess its biological significance. Methods: Fifty-seven patients with OCCA were enrolled. We used formalin-fixed, paraffin-embedded sections of the primary tumor obtained at the first operation to investigate the immunohistochemical expression of PAI-1 and the association of PAI-1 expression with various clinico-pathologic factors. Results: The 57 patients were classified into a high PAI-1 expression group and a low expression group. Comparison between the two groups revealed that the percentage of patients with concomitant endometriosis was significantly larger in the high expression group, while the percentage of Stage I patients with positive peritoneal cytology was significantly larger in the low expression group. Comparison of cumulative 5-year survival rates showed that the high expression group had a better prognosis than the low expression group. Conclusion: These data suggest an association between concomitant endometriosis and increased expression of PAI-1 in OCCA. The data also suggest that PAI-1 expression influences both peritoneal dissemination of early OCCA and the prognosis.

AB - Purpose: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasminogen activator inhibitor-1 (PAI-1) expression in patients with OCCA and attempted to assess its biological significance. Methods: Fifty-seven patients with OCCA were enrolled. We used formalin-fixed, paraffin-embedded sections of the primary tumor obtained at the first operation to investigate the immunohistochemical expression of PAI-1 and the association of PAI-1 expression with various clinico-pathologic factors. Results: The 57 patients were classified into a high PAI-1 expression group and a low expression group. Comparison between the two groups revealed that the percentage of patients with concomitant endometriosis was significantly larger in the high expression group, while the percentage of Stage I patients with positive peritoneal cytology was significantly larger in the low expression group. Comparison of cumulative 5-year survival rates showed that the high expression group had a better prognosis than the low expression group. Conclusion: These data suggest an association between concomitant endometriosis and increased expression of PAI-1 in OCCA. The data also suggest that PAI-1 expression influences both peritoneal dissemination of early OCCA and the prognosis.

KW - Clear cell adenocarcinoma

KW - Endometriosis

KW - Ovarian cancer

KW - Peritoneal cytology

KW - Plasminogen activator inhibitor-1

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84855477766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855477766&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 611

EP - 614

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 6

ER -